NCT02024542 Metabolic Responses to Bariatric Surgery
| NCT ID | NCT02024542 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Davis |
| Condition | Morbid Obesity |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2011-02 |
| Primary Completion | 2035-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2011-02 with a primary completion date of 2035-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Research the genetic and biomechanical markers of human adipose tissue on patients with morbid obesity. Additional tissue/fluid collection is also gathered during the time of surgery.
Eligibility Criteria
Inclusion Criteria: * Meet NIH Criteria for Bariatric Surgery * Between the Age of 18-55 * Dyslipidemia controlled with medication * Impaired glucose metabolism or type 2 diabetes Exclusion Criteria: * Uncontrolled Metabolic syndrome (uncontrolled diabetes, htn, dyslipidemia), one or all conditions.
Contact & Investigator
Mohamed R Ali, MD
PRINCIPAL INVESTIGATOR
University of California Davis Health System
Frequently Asked Questions
Who can join the NCT02024542 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 55 Years, studying Morbid Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02024542 currently recruiting?
Yes, NCT02024542 is actively recruiting participants. Contact the research team at mrali@ucdavis.edu for enrollment information.
Where is the NCT02024542 trial being conducted?
This trial is being conducted at Sacramento, United States.
Who is sponsoring the NCT02024542 clinical trial?
NCT02024542 is sponsored by University of California, Davis. The principal investigator is Mohamed R Ali, MD at University of California Davis Health System. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.